Table 1 Demographics, comorbidities, symptoms and laboratory results of patients
|  | Total N = 231 | Survivors N = 176 | Non-survivors N = 55 |
|---|---|---|---|
Age, years | |||
 Mean ± SD | 61.46 ± 13.99 | 59.91 ± 14.31 | 66.42 ± 11.69 |
 Median (IQR) | 63 (53, 72) | 60 (51.25, 71) | 66 (60, 75) |
Dialysis vintage, months | |||
 Median (IQR) | 36 (16, 72) | 36 (16.25, 71.5) | 36 (12, 72) |
Sex, M/F, n(%) | 128/103 (55.4/44.6) | 96/80 (54.5/45.5) | 32/23 (58.2/41.8) |
Smoking, n(%) | 61 (26.4) | 46 (26.1) | 15 (27.3) |
Hypertension, n(%) | 201 (87) | 151 (85.8) | 50 (90.9) |
Diabetes, n(%) | 111 (48.1) | 79 (44.9) | 32 (58.2) |
Obesity, n(%) | 52 (22.5) | 41 (23.3) | 11 (20) |
Coronary Artery Disease, n(%) | 91 (39.4) | 56 (31.8) | 35 (63.6) |
Heart failure, n(%) | 38 (16.5) | 18 (10.2) | 20 (36.4) |
History of stroke, n(%) | 14 (6.1) | 7 (4) | 7 (12.7) |
Lung disease, n(%) | 26 (11.3) | 16 (9.1) | 10 (18.2) |
Dementia, n(%) | 6 (2.6) | 2 (1.1) | 4 (7.3) |
Cancer, n(%) | 21 (9.1) | 13 (7.4) | 8 (14.5) |
Fever, n(%) | 183 (79.2) | 131 (74.4) | 52 (94.5) |
Dry cough, n(%) | 150 (64.9) | 101 (57.4) | 49 (89.1) |
Dyspnea, n(%) | 110 (47.6) | 62 (35.2) | 48 (87.3) |
Diarrhea, n(%) | 56 (24.2) | 45 (25.6) | 11 (20) |
Loss of smell and taste, n(%) | 27 (11.7) | 24 (13.6) | 4 (7.3) |
Other/Fatigue, n(%) | 18 (7.8) | 15 (8.5) | 3 (5.4) |
Other/Chills, n(%) | 12 (5.2) | 12 (6.8) | 0 |
Other/Lethargy, n(%) | 10 (4.3) | 8 (4.5) | 2 (3.6) |
Other/Headache, n(%) | 6 (2.6) | 6 (3.4) | 0 |
Asymptomatic, n(%) | 23 (10) | 10 (5.7) | 0 |
CRP mg/L, Median (IQR) | 86.5 (35.3, 190) | 69 (27, 150) | 143 (74, 233) |
Serum Albumin g/L, Median (IQR) | 35 (33, 38) | 36.4 (33.5, 40) | 30 (24, 35.5) |
Neutrophil/Lymphocyte ratio, Median (IQR) | 4.8 (2.4, 7.2) | 4.8 (2.3, 7.2) | 4.8 (3.6, 6.8) |